Sei qui!

Nella città di Milano

Con gli esperti nello sviluppo di prodotti sanitari e di collaborazioni commerciali

Benvenuto in BMG Pharma

BMG è un’azienda all’avanguardia con anni di esperienza nello sviluppo e nella partnership internazionale di prodotti biofarmaceutici.

Gli obiettivi finali delle altre aziende per noi sono solo punti di partenza.

Crediamo che la trasparenza
sia un valore fondamentale.

PR FESR 2021-27 – Ricerca e Sviluppo Bando 2022

PR FESR 2021-27 – Ricerca e Sviluppo Bando 2022

SVILUPPO DI BIOMATERIALI INNOVATIVI UTILI NELLA MEDICINA RIGENERATIVA A BASE DI DERIVATI BIOCOMPATIBILI DI SODIO IALURONATO CON FUNZIONALI BIOLOGICAMENTE ATTIVI. Beneficiario: BMG Pharma® SpA Spesa ammessa: 739.625,51 Euro Contributo concesso: 313.899,64 Euro ...

Ultime novità

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box “, the innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html

Ultime novità

PR FESR 2021-27 – Ricerca e Sviluppo Bando 2022

PR FESR 2021-27 – Ricerca e Sviluppo Bando 2022

SVILUPPO DI BIOMATERIALI INNOVATIVI UTILI NELLA MEDICINA RIGENERATIVA A BASE DI DERIVATI BIOCOMPATIBILI DI SODIO IALURONATO CON FUNZIONALI BIOLOGICAMENTE ATTIVI. Beneficiario: BMG Pharma® SpA Spesa ammessa: 739.625,51 Euro Contributo concesso: 313.899,64 Euro ...

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box “, the innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html